bibliographicCitation |
Velentza L, Wickström M, Kogner P, Ohlsson C, Zaman F, Sävendahl L. Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth. Sci Rep. 2023 May 17;13(1):8054. PMID: 37198212; PMCID: PMC10192431. |